Pure Global

ALINITY I ANTI-HBc IgM CONTROL - FDA Registration IVDR-00361C

Access comprehensive regulatory information for ALINITY I ANTI-HBc IgM CONTROL in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number IVDR-00361C and manufactured by Abbott GmbH & Co. KG in Germany. The device was registered on January 14, 2020.

This page provides complete registration details including manufacturer information, importer/distributor details (Abbott Laboratories), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.

Free Database
Powered by Pure Global AI
FDA Official Data
Germany
IVDR-00361C
ALINITY I ANTI-HBc IgM CONTROL
Registered medical device in Philippines
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Information
Product Name
ALINITY I ANTI-HBc IgM CONTROL
Registration Number
IVDR-00361C
Manufacturer Details
Country of Origin
Germany
Importer & Distribution
Importer/Distributor
Abbott Laboratories
Registration Dates
Issuance Date
January 14, 2020
Expiry Date
January 09, 2025